March 20, 2023

Press Release: OncoHelix and Oxford Cancer Biomarkers Enter into a Partnership to Offer Breakthrough Cancer Genetic Screening Test to Canadians

March 20, 2023: Oxford Cancer Biomarkers (OCB) and OncoHelix today announce a new partnership to offer OCB’s advanced genetic tests in Canada for screening and detection of people at risk for colorectal cancer. Based on ground-breaking research at the University […]